Data compiled by Redley Lamar · ChainSifter Intelligence
5Suppliers
7Customers
3Debt Items
20Related Chains
Source-Backed Evidence Depth
Vyome Holdings, Inc. (HIND) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
22Total relationships
5Distinct source URLs
15High confidence
0.854Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Vyome Holdings, Inc. Suppliers
Ticker
Name
Confidence
Evidence
MAXIM-GROUP-LLC
MAXIM-GROUP-LLC
92%
The Company entered into Amendment No. 1 to the Equity Distribution Agreement dated May 30, 2025 (the “Sales Agreement” or “ATM”) with Maxim Group LLC ("Maxim") to act as the Company’s exclusive sale…
REMUS-CAPITAL-SERIES-B-II-L-P
REMUS-CAPITAL-SERIES-B-II-L-P
92%
the Buyer will acquire senior secured convertible notes in the aggregate principal amount of $5,765,000 issued by Humanyze and held by Remus
HUMANYZE
HUMANYZE
85%
Remus will have the right to appoint one director to the LICH board immediately after closing. The LICH board and CEO will use their best efforts to raise capital as needed. As a condition to closing…
SNYNF
Sanofi
72%
or interference proceedings challenging our patent rights or the patent rights of others. An adverse determination in any such submission, proceeding or litigation could reduce the scope of, or inval…
SNYNF
Sanofi
72%
Reciprocal relationship from SNYNF graph: Reciprocal relationship from HIND graph: Reciprocal relationship from SNYNF graph: Reciprocal relationship from HIND graph: or interference proceedings chall…
Vyome Holdings, Inc. Customers
Ticker
Name
Confidence
Evidence
HUMANYZE
HUMANYZE
90%
following the Closing, Remus agreed to ensure that Humanyze remains active and in good standing for purposes of servicing select existing debts, liabilities, and other obligations
SUN-PHARMA
SUN-PHARMA
90%
various licensing agreements with Sun Pharma
SNYNF
Sanofi
72%
Reciprocal relationship from SNYNF graph: Reciprocal relationship from HIND graph: t such party. Costly and time- consuming litigation could be necessary to enforce and determine the scope of our pro…
SNYNF
Sanofi
72%
t such party. Costly and time- consuming litigation could be necessary to enforce and determine the scope of our proprietary rights and failure to obtain or maintain trade secret protection could adv…
Reciprocal relationship from THCH graph: Reciprocal relationship from HIND graph: nti-fungal product in India, whereby the Company will receive a net service fee payment for sales of such products ma…
nti-fungal product in India, whereby the Company will receive a net service fee payment for sales of such products made by Sun Pharma. This agreement terminated in 2024. The Company had also entered …
OTC-MARKETS-GROUP
OTC-MARKETS-GROUP
62%
and related allowances for depreciation and amortization are eliminated from the accounts, and any resulting gain or loss is reflected in operations. 8 i) Goods and Service Tax and Other Credits Rece…
Vyome Holdings, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
HIND-DEBT-3752
Warrants outstanding: 6008589
90%
xbrl warrant detail from xbrl 2025-12-31.
HIND-DEBT
Debt stack $10.0M
90%
Market cache reports total debt of $10.0M.
HIND-DEBT-3753
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2025-12-31.
Vyome Holdings, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Vyome Holdings, Inc..
Vyome Holdings, Inc. Ownership
Holder
Name
Confidence
Evidence
HIND-OWNER-UBS-GROUP-AG
UBS Group AG
95%
13F/ownership overlay lists UBS Group AG; shares held 3,959; ownership 0.07%; value $8,670; as of 2025-12-31.
HIND-OWNER-MORGAN-STANLEY
Morgan Stanley
95%
13F/ownership overlay lists Morgan Stanley; shares held 118; value $258; as of 2025-09-30.
HIND-OWNER-HIGHTOWER-ADVISORS-LLC
HighTower Advisors, LLC
95%
13F/ownership overlay lists HighTower Advisors, LLC; shares held 17,973; ownership 0.32%; value $39,360; as of 2025-09-30.
HIND-OWNER-BANK-OF-AMERICA-CORPORATION
Bank of America Corporation
95%
13F/ownership overlay lists Bank of America Corporation; shares held 6; value $13; as of 2025-09-30.
HIND-OWNER-VANGUARD-GROUP-INC
Vanguard Group Inc
95%
13F/ownership overlay lists Vanguard Group Inc; shares held 12,195; ownership 0.22%; value $26,707; as of 2025-12-31.
HIND-OWNER-KOVITZ-INVESTMENT-GROUP-PARTNERS-LLC
Kovitz Investment Group Partners, LLC
95%
13F/ownership overlay lists Kovitz Investment Group Partners, LLC; shares held 14,640; ownership 0.26%; value $32,061; as of 2025-09-30.
HIND-OWNER-ROYAL-BANK-OF-CANADA
Royal Bank of Canada
95%
13F/ownership overlay lists Royal Bank of Canada; shares held 5,856; ownership 0.10%; value $12,824; as of 2025-09-30.
Vyome Holdings, Inc. Extended Supply Chain Network
